Showing results (151-160 of 159) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancerSumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.American Journal of Clinical Oncology|August 1, 1985
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureJ N Ingle, D M Pfeifle, S J Green, et al.Clinical Oral Investigations|October 31, 2013
In vitro optical detection of simulated blood pulse in a human tooth pulp modelA Niklas, K-A Hiller, A Jaeger, et al.European Archives of Psychiatry and Clinical Neuroscience|November 30, 2010
A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobiaA Wittmann, F Schlagenhauf, T John, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.Clinical Pharmacology and Therapeutics|November 29, 2023
Non-Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion PieceGraeme C Young, Douglas K Spracklin, Alexander D James, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2024
Recommendations on the Use of Multiple Labels in Human Mass Balance StudiesFilip Cuyckens, Mette G Hvenegaard, Kenneth C Cassidy, et al.Clinical Pharmacology and Therapeutics|June 23, 2022
Considerations for Human ADME Strategy and Design Paradigm Shift(s) - An Industry White PaperGraeme C Young, Douglas K Spracklin, Alexander D James, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation StudyP Scherer, I K Penner, A Rohr, et al.Pageof 16